Consumer Reports: Alzheimer's drugs are costly, ineffective

01/8/2013 | Washington Post, The

Drugs approved to treat Alzheimer's disease are expensive and are not really effective for many patients, according to Consumer Reports Best Buy Drugs. The report said none of the drugs could be considered a "Best Buy," based on analyses from several health care organizations, and that they had side effects that could be debilitating for older patients.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC